Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Health perceptions in patients who undergo screening and workup for prostate cancer.

Katz DA, Jarrard DF, McHorney CA, Hillis SL, Wiebe DA, Fryback DG.

Urology. 2007 Feb;69(2):215-20.

2.

Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.

Cohen L, Fouladi RT, Babaian RJ, Bhadkamkar VA, Parker PA, Taylor CC, Smith MA, Gritz ER, Basen-Engquist K.

Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):610-7.

3.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
4.

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, Lane JA, Peters TJ.

BJU Int. 2006 Oct;98(4):777-82.

5.

Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.

Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA Jr.

J Clin Oncol. 2007 Jul 20;25(21):3076-81.

PMID:
17634486
6.

Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population.

Ankerst DP, Miyamoto R, Nair PV, Pollock BH, Thompson IM, Parekh DJ.

J Urol. 2009 May;181(5):2071-5; discussion 2076. doi: 10.1016/j.juro.2009.01.029. Epub 2009 Mar 14.

7.

Patients' perceptions of quality of life after treatment for early prostate cancer.

Clark JA, Inui TS, Silliman RA, Bokhour BG, Krasnow SH, Robinson RA, Spaulding M, Talcott JA.

J Clin Oncol. 2003 Oct 15;21(20):3777-84.

PMID:
14551296
8.

Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy.

Kobayashi M, Nukui A, Kamai T.

Int J Clin Oncol. 2017 Feb;22(1):174-180. doi: 10.1007/s10147-016-1038-1. Epub 2016 Sep 8.

PMID:
27631094
9.

Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.

Faria EF, Carvalhal GF, dos Reis RB, Tobias-Machado M, Vieira RA, Reis LO, Nogueira L, Machado RD, Freitas CH Jr, Magnabosco WJ, Mauad EC, Carvalho AL.

BJU Int. 2012 Dec;110(11 Pt B):E653-7. doi: 10.1111/j.1464-410X.2012.11398.x. Epub 2012 Aug 14.

10.

Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.

Heyns CF, Mathee S, Isaacs A, Kharwa A, De Beer PM, Pretorius MA.

BJU Int. 2003 Jun;91(9):785-8.

11.
12.

Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.

Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.

J Urol. 2008 Oct;180(4):1325-9; discussion 1329. doi: 10.1016/j.juro.2008.06.022. Epub 2008 Aug 15.

PMID:
18707706
13.

Psychological distress in Japanese men with localized prostate cancer.

Namiki S, Saito S, Tochigi T, Numata I, Ioritani N, Arai Y.

Int J Urol. 2007 Oct;14(10):924-9.

14.

Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR.

Urology. 2002 Apr;59(4):560-5.

PMID:
11927314
15.
18.

The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Fowler FJ Jr, Barry MJ, Walker-Corkery B, Caubet JF, Bates DW, Lee JM, Hauser A, McNaughton-Collins M.

J Gen Intern Med. 2006 Jul;21(7):715-21.

19.

Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.

Vasarainen H, Lokman U, Ruutu M, Taari K, Rannikko A.

BJU Int. 2012 Jun;109(11):1614-9. doi: 10.1111/j.1464-410X.2011.10677.x. Epub 2011 Nov 1.

20.

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values.

Keetch DW, Catalona WJ, Smith DS.

J Urol. 1994 Jun;151(6):1571-4.

PMID:
7514690

Supplemental Content

Support Center